Humanigen, Inc. (HGEN)
OTOTC · Common · CUSIP 444863203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HGEN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
444863203 (prev. 444863104 )
Market Cap
Micro Cap
Previous Symbol
HGEND (changed 9/18/2020)
Business: Humanigen, Inc. is a clinical-stage biopharmaceutical company developing its portfolio of next-generation cell and gene therapies for the treatment of cancers via its novel, GM-CSF neutralization and gene-knockout platforms.

Company Contact

CEO
Cameron Durrant
CFO
Timothy Morris
Headquarters
830 Morris Turnpike, 4th Floor, Short Hills, NJ 07078
Phone
650-243-3100
Investor Relations
Victoria Meissner, Westwicke · 646-866-4012 · victoria.meissner@westwicke.com
General Email
ir@humanigen.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »